middle.news
BCAL Diagnostics Names Anne-Louise Arnett as CEO to Drive Commercial Expansion
8:50am on Monday 11th of May, 2026 AEST
•
Healthcare
Read Story
BCAL Diagnostics Names Anne-Louise Arnett as CEO to Drive Commercial Expansion
8:50am on Monday 11th of May, 2026 AEST
Key Points
Anne-Louise Arnett appointed CEO from 1 June 2026
Over 25 years of medical technology leadership experience
Shane Ryan shifts to Director Clinical Affairs Breast Cancer
Executive Chair Jayne Shaw transitions to Non-Executive Chair
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bcal Diagnostics (ASX:BDX)
OPEN ARTICLE